Show simple item record

dc.contributor.authorObamiro, K.
dc.contributor.authorChalmers, Leanne
dc.contributor.authorLee, K.
dc.contributor.authorBereznicki, B.
dc.contributor.authorBereznicki, L.
dc.date.accessioned2018-05-18T07:57:48Z
dc.date.available2018-05-18T07:57:48Z
dc.date.created2018-05-18T00:22:54Z
dc.date.issued2018
dc.identifier.citationObamiro, K. and Chalmers, L. and Lee, K. and Bereznicki, B. and Bereznicki, L. 2018. Adherence to Oral Anticoagulants in Atrial Fibrillation: An Australian Survey. Journal of Cardiovascular Pharmacology and Therapeutics.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/67242
dc.identifier.doi10.1177/1074248418770201
dc.description.abstract

© 2018, The Author(s) 2018. Background: The aim of this study was to investigate the proportion of patients who have suboptimal adherence to oral anticoagulant (OAC), identify the predictors of adherence, and determine whether patient-related factors vary across adherence levels in Australia. Methods: Respondents were recruited for an online survey using Facebook. Survey instruments included the Morisky Medication Adherence Scale, the Anticoagulation Knowledge Tool, the Perception of Anticoagulant Treatment Questionnaires, and a modified Cancer Information Overload scale. Predictors of medication adherence were identified using ordinal regression analysis. Results: Of the 386 responses eligible for analysis, only 54.9% reported a high level of adherence. Participants aged 65 years or younger were less likely to have high adherence compared to older participants (odds ratio [OR], 0.54; 95% confidence interval [CI] , 0.33-0.88; P =.013), while females were more likely to be highly adherent compared to males (OR, 1.69; 95% CI, 1.08-2.64; P =.023). The analyses showed that age, gender, treatment satisfaction, information overload, concerns about making mistake when taking OACs, and cost of medication were significant predictors of adherence. Conclusion: Self-reported suboptimal adherence to OAC is common among patients with atrial fibrillation. A focus on supporting people who are at higher risk of suboptimal adherence is needed to maximize the benefit of OAC therapy in this population.

dc.titleAdherence to Oral Anticoagulants in Atrial Fibrillation: An Australian Survey
dc.typeJournal Article
dcterms.source.issn1074-2484
dcterms.source.titleJournal of Cardiovascular Pharmacology and Therapeutics
curtin.departmentSchool of Pharmacy and Biomedical Sciences
curtin.accessStatusFulltext not available


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record